Page 2 - Marie Utter News Today

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price target hoisted by JPMorgan Chase & Co. from $57.00 to $64.00 in a research note published on Monday morning, The Fly reports. A number of other equities analysts have also commented on PTCT. Credit Suisse Group boosted their price target on shares of PTC Therapeutics from […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) – Research analysts at Jefferies Financial Group cut their FY2026 earnings per share (EPS) estimates for PTC Therapeutics in a research note issued on Thursday, April 27th. Jefferies Financial Group analyst K. Shi now expects that the biopharmaceutical company will post earnings of $1.99 per share for the […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price increased by Credit Suisse Group from $48.00 to $51.00 in a research report released on Friday morning, The Fly reports. Other research analysts have also recently issued reports about the company. SVB Leerink reissued a market perform rating and issued a $48.00 target price on […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price upped by stock analysts at Credit Suisse Group from $48.00 to $51.00 in a report issued on Friday, The Fly reports. Credit Suisse Group’s target price would suggest a potential downside of 7.51% from the company’s previous close. Other analysts have also recently issued research […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price objective raised by Citigroup from $61.00 to $67.00 in a research note issued to investors on Friday morning, The Fly reports. Other equities analysts also recently issued research reports about the stock. SVB Leerink reaffirmed a market perform rating and set a $48.00 price target on […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

PTC Therapeutics (NASDAQ:PTCT – Get Rating) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.64) by ($0.24), Briefing.com reports. The firm had revenue of $220.38 million during the quarter, compared to analyst estimates of $200.48 million. The business’s revenue […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 4,692 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $55.06, for a total transaction of $258,341.52. Following the transaction, the chief accounting officer now directly owns 38,059 shares […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) has earned an average rating of “Hold” from the fifteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have assigned a buy recommendation to the company. The […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 4,688 shares of the business’s stock in a transaction dated Wednesday, March 29th. The stock was sold at an average price of $47.79, for a total transaction of $224,039.52. Following the completion of the transaction, the chief accounting officer now directly owns 38,059 […]